Substance
ID:361725
Names and Identifiers
Synonyms
Ketanserin (+)-tartrate salt3-(2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione (+)-tartrate saltR 41468 (+)-tartrate salt
IUPAC name
(2R,3R)-2,3-dihydroxybutanedioic acid; 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione
IUPAC Traditional name
L(+)-tartaric acid; ketanserin
Properties
Product Information
Empirical Formula (Hill Notation)
C22H22FN3O3 · C4H6O6
Purity
≥98.0% (TLC)
Safety Information
GHS Hazard statements
H301
Personal Protective Equipment
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
GHS Precautionary statements
P301+P310
Safety Statements
22-36/37/39-45
GHS Signal Word
Danger
European Hazard Symbols
Toxic (T)MSDS Link
RTECS
VA1411195
German water hazard class
3
Hazard Class
6.1
GHS Pictograms
Acute toxicity (oral, dermal, inhalation), categories 1,2,3
RID/ADR
UN 2811 6.1/PG 3
Risk Statements
25
UN Number
2811
Packing Group
3
Molecule Details
Biochem/physiol Actions
Selective 5-HT2 serotonin receptor antagonist. Ketanserin significantly reduces nicotine self-administration in rats, supporting an unexpected involvement of serotonin in nicotine addiction.1
Selective 5-HT2 serotonin receptor antagonist. Ketanserin significantly reduces nicotine self-administration in rats, supporting an unexpected involvement of serotonin in nicotine addiction.1
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data